0001209191-18-049446.txt : 20180905 0001209191-18-049446.hdr.sgml : 20180905 20180905130047 ACCESSION NUMBER: 0001209191-18-049446 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180901 FILED AS OF DATE: 20180905 DATE AS OF CHANGE: 20180905 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Williams Lewis T CENTRAL INDEX KEY: 0001475714 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36070 FILM NUMBER: 181054596 MAIL ADDRESS: STREET 1: C/O FIVE PRIME THERAPEUTICS, INC. STREET 2: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC CENTRAL INDEX KEY: 0001175505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260038620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-365-5600 MAIL ADDRESS: STREET 1: 111 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-09-01 0 0001175505 FIVE PRIME THERAPEUTICS INC FPRX 0001475714 Williams Lewis T 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 1 1 0 0 Executive Chairman Common Stock 2018-09-01 4 F 0 7024 14.00 D 374213 D /s/ Francis Sarena, Attorney-in-Fact 2018-09-05